CasNo.142340-99-6,Adefovir dipivoxil,(142340-99-6) Suppliers

1 Kilogram	FOB Price:USD 65.0000 -75.0000

Min.Order :1 Kilogram
Purity: 98%
Payment Terms : T/T,MoneyGram,Other

Keywords

Adefovir dipivoxil BIS POM PMEA AdefovirDipivoxl98.5%Min

Quick Details

Appearance:White powder
Application:It has broad-spectrum antiviral activity and can be used in the treatment of chronic hepatitis B
PackAge:Fiber can/Drum/Bag
ProductionCapacity:100|Kilogram|Day
Storage:Seal and store in a cool and dry place
Transportation:By sea/air/land

Superiority:

1. Product advantages
High purity, all above 98.5%, no impurities after dissolution
We will test each batch to ensure quality
OEM and private brand services designed for free
Various cap colors available
We can also provide MT1 peptide powder
2. Factory advantages
Professional research team
More than 5 doctors in high-tech R&D laboratories
More than 1000 m2 of factory production line to ensure stable supply
More than 1200 factories to manufacture products and control quality
3. Service advantages
24-hour online service
Track package information and update it for customers
Professional sales team
Accept small order service
Redelivery service if detained by customs

Details:

Product Introduction:

Adefovir dipivoxil is an oral broad-spectrum antiviral originally synthesized by Gilead in the United States and approved by the FDA for marketing in the United States in September 2002. It is also another oral anti-HBV drug after lamivudine. Adefovir dipivoxil is recommended by the American Association for the Study of Liver Diseases, the Asia Pacific Association for the Study of Liver, and the Chinese "Chronic Hepatitis B Prevention and Treatment Guideline" as the first-line option for newly treated patients. Adefovir diaxidate can inhibit the activity of HBVDNA polymerase, and can penetrate into the DNA of hepatitis B virus, inhibit the replication of the virus, and have a strong inhibitory effect on lamivudine and famiclovir resistant HBV virus strains, which is clinically used in the treatment of hepatitis.

Ademovir dipivoxil, a nucleoside analogue reverse transcriptase inhibitor (NRTI) for the treatment of patients aged 12 years and older with chronic hepatitis B, developed by Gilead, Inc., approved by the US FDA in September 2002, approved by the European EMA in March 2003, approved by the Japanese PMDAChemicalbook in October 2004. It was first marketed in the United States by Gilead under the brand name Hepsera®. For the treatment of adult chronic hepatitis B patients with evidence of active hepatitis B virus replication and liver function compensation with persistent elevated serum amino acid transferase (ALT or AST) or histologically active lesions of the liver.

It has broad-spectrum antiviral activity and can be used in the treatment of chronic hepatitis B

It is used to study organ-specific toxicity and immune mechanism of adefovir therapy

Hebei Sankai Chemical Technology Co., Ltd. is a new chemical enterprise integrating the research, manufacturing and supply of chemicals. Located in the beautiful "cattle city" Xingtai, Hebei Sankai Chemical Technology Co., Ltd. is mainly engaged in the research of chemical fertilizer. At the same time, we have made great breakthroughs in food, feed additives, cosmetics, dyes and industrial chemicals. Our company spirit of "integrity management, quality control, customer first" belief, at home and abroad enjoy high reputation.